Skip to main content

Gujarat Ambuja Exports Ltd

NSE: GAEL BSE: 524226Pharma

Gujarat Ambuja Exports is engaged in the manufacturing of Corn Starch Derivatives, Soya Derivatives, Feed Ingredients, Cotton Yarn, and Edible Oils. Since its incorporation in 1991, GAEL strives to serve the Food, Pharmaceutical, Feed, and many other industries with a long-term growth strategy in the Agro-Processing sector. (Source: Company Website)

160
52W: ₹101 — ₹178
PE 23.9 · Book ₹71.9 · +123% vs book
Market Cap₹7,362 Cr
Stock P/E23.9Price to Earnings
ROCE12.5%Return on Capital
ROE9.78%Return on Equity
Div. Yield0.15%Face Value ₹1

Weaknesses

  • The company has delivered a poor sales growth of 4.01% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.
  • Dividend payout has been low at 4.58% of profits over last 3 years

Shareholding Pattern

Promoters63.84%
FIIs2.18%
DIIs0.82%
Public33.14%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters63.84%63.84%63.84%63.84%63.84%63.84%63.84%63.84%
FIIs4.24%1.99%2.31.87%0.12.02%0.12.17%0.12.04%0.11.6%0.42.18%0.6
DIIs1.39%0.63%0.80.39%0.20.51%0.10.19%0.30.6%0.40.57%0.00.82%0.3
Public30.52%33.53%3.033.9%0.433.62%0.333.8%0.233.51%0.333.97%0.533.14%0.8

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales1,3021,3461,0901,1251,1311,2671,2911,4871,4841,466
Expenses1,1761,2359851,0151,0081,2041,1951,4111,3851,272
Operating Profit125111106110123629676100195
OPM %10%8%10%10%11%5%7%5%7%13%
Net Profit1019177707233653866135
EPS ₹2.191.991.671.521.570.711.430.831.442.95

AI Insights

Revenue Trend

Mar 2026 revenue at ₹5,729Cr, up 24.2% YoY. OPM at 8%.

Debt Position

Borrowings at ₹440Cr. Debt-to-equity ratio: 0.14x. Healthy balance sheet.

Capex Cycle

CWIP at ₹316Cr (27% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 0.82% (+0.66pp change). FIIs: 2.18% (-1.81pp change). Promoters hold 63.84%.

Margin & Efficiency

ROCE improving from 9% (Mar 2015) to 13% (Mar 2026). Working capital days: 96.

Valuation

PE 23.9x with 12.5% ROCE. Price is 123% above book value of ₹71.9. Dividend yield: 0.15%.

Recent Announcements